ANIP vs TECH · rev $614.4M vs P/E 65, rev $1.22B
ANI Pharmaceuticals Inc (ANIP) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ANIP revenue for 2024-12-31 was $614.4M. Net income was -$18.5M. Revenue was up 26.2% from 2023-12-31 to 2024-12-31. ANIP currently screens at market cap $1.41B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ANIP currently screens at market cap $1.41B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ANIP and TECH stock pages for the full models.
Not investment advice.